Please login to read the full article.
Scrip Regulatory Affairs
India consults on draft guideline for approving clinical trials and new drugs
26 July 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA concerned over negotiations schedule for next medtech user fee programme
- Canada helps importers, distributors prepare for initial GMP inspection
- EU finalises guidance on reporting adverse events from clinical trials
- ICH allows first non-ICH regulators into QSE working groups; guidelines progress announced
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
FEATURES
Regulatory Affairs Pharma Features
COMMENT
Other Informa Comments
